The Covid-19-causing coronavirus is mutating while spreading around the world in the pandemic, but none of the mutations currently documented appears to be making the SARS-CoV-2 virus able to spread more rapidly, scientists said.
A review of recently published scientific studies includes a look at the potential of using flu and pneumonia vaccines to decrease the risk of developing Alzheimer’s disease.
British researchers will study the genes of thousands of ill COVID-19 patients to try to crack one of the most puzzling riddles of the novel coronavirus: why does it kill some people but give others not even a mild headache?
A series of studies of the genomes of thousands of samples of the new coronavirus show that SARS-CoV-2 is mutating and evolving while adapting to human hosts.
Dr. Anthony Fauci – who has been considered one of the most trusted leaders tackling the COVID-19 pandemic in the United States – once again stressed that, as far as the evidence suggests, the novel coronavirus is naturally occurring and was not made in a laboratory.
A review of some recently published scientific studies, including researchers at the University of Maryland Baltimore County identifying a single nucleotide that controls two forms of the HIV virus’ RNA.
Illumina and Pacific Biosciences called off their $1.2 billion merger fourteen months after the deal was announced.
Researchers at the University of California, San Diego (UCSD) School of Medicine have identified a key switch that has the potential to eliminate dormant HIV reservoirs.
British drugmaker AstraZeneca Plc and French biopharmaceutical firm Transgene SA entered into an agreement to jointly develop five cancer-killing viral immunotherapies.
Personal Genome Diagnostics Inc. reported that the cancer genomics company’s 500+ gene pan-cancer tumor profiling tissue assay is being used in Merck’s Phase 2 precision oncology KeyImPaCT study of biomarker-directed, pembrolizumab-based combination therapy for advanced non-small-cell lung cancer (KEYNOTE-495).